CIK 0000939767 · Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043257395
- Phone
- 6508377000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-24 | MORRISSEY MICHAEL President and CEO | Gift | +177,985 | 1,764,985 | ||
| 2025-02-24 | Senner Christopher J. EVP and CFO | Option exercise | +29,314 | $18.80 | $551K | 808,921 |
| 2025-02-24 | Senner Christopher J. EVP and CFO | Sale | −29,314 | $36.14 | $1.1M | 779,607 |
| 2025-02-24 | Senner Christopher J. EVP and CFO | Option exercise · Option (right to buy) | −29,314 | 100,000 | ||
| 2025-02-15 | Senner Christopher J. EVP and CFO | Shares withheld for taxes | −21,591 | $35.00 | $756K | 779,607 |
| 2025-02-14 | Beckerle Mary C Director | Option exercise | +8,354 | $23.24 | $194K | 42,616 |
| 2025-02-14 | Beckerle Mary C Director | Sale | −8,354 | $34.87 | $291K | 34,262 |
| 2025-02-14 | Beckerle Mary C Director | Sale | −3,856 | $34.90 | $135K | 30,406 |
| 2025-02-14 | Beckerle Mary C Director | Option exercise · Option (right to buy) | −8,354 | 22,494 | ||
| 2025-02-14 | POSTE GEORGE Director | Option exercise | +15,874 | $20.50 | $325K | 184,894 |
| 2025-02-14 | POSTE GEORGE Director | Sale | −15,874 | $34.74 | $551K | 169,020 |
| 2025-02-14 | POSTE GEORGE Director | Option exercise · Option (right to buy) | −15,874 | 0 |
Page 10 of 10 · 192 trades